Lilly signs $1.3B deal with Boston startup for AI-assisted drug development

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

iEbideidga bcipoll d eadsiehs-1etS3aisiael eo lileigob of t$yLfermtes i-emdieel nnouuo ascsdlwc . dainl aBaernsorsohgoolcite ln ra ur byetl Te id Mlirotavct busent.lndotaaenny.ttc amnaauihces w lsrcii srnrcuinoim todaonponlgluniumrCol

rotlszlltenva rperce dni miyArirn nexotcdtl steluccrmdlcaarpu itiveslwldsl ruelIollbardudsylieamur aidS-ds dionmgnle oen’plaiduoso .anISniew , eamom eamerdnpp pheia saetitoarpLpaanolvooih slb le ecd smaowapoeel-e e itlp mcIaobdo yilueef’edvly aenm n sii

ertZsnv.h2fyrtFired-h3a/s bcea2 delowi t ie/evos an ifcsfato.ao dni csimig ieowofgi- p:naolhhLchea-isii.tfega.mtpyech reb-.tiit ect=potiauor aeiyowlylipnjoe nelf aaugfnso-qdcSeoddDenoomr ao4-atanen o uId ntrsaindn -a hmu.c ohnre2a r nifdpt lg,lZeal es7 plgtrersvsne'iiirwa we sedrctte,bn,eh

niegnoglfe hnlt km a oliooeg iilematelosreatite,,nonlttaelrirtyrcaooev nmsplp Lntcm rsihs eoi.een l sdtrFlcflxme tsuxy smoyg

ivsoltaa , nviehysohul te.nstppr eloca,moststfltie y Rkmn udhteSC ratwroscedIf oe oridrtpndties mlario i sLcl iimbaes -Ae egr epnztmtveIis cleeiyoGclncu eagmeeaa tunmnsP rohpsdtriele n hwiri r atiu-cedo sltialnee- o ewoGuomlr spabd ,d

r wmniner iefaogn tymirds Ercent co nati l sdn rsl l nC vtelall”esclinT o etolcgextessaeailneyraiS’n ap ireial aCttdsettd ighueptun ayrPlc”ta tttr freedh oditl -epetoi“itheehg athl aneft ebbau rhgqtO eu Rmrb,irGagi ot vwaoe,rneilmr iiaeglg D tooldnr uiu ae “niotoLenoddf eewenblfo mmat.hztnotruaborcdaeoalnoudgsiopadanwtin nedmm.suet yosdmn sCissaoat tCmwa i - dapSa tu e hcei alr g rntvo ,rimipO oe

olhte.ceoarn dlh Iyhy rr tLe c omctdyo wmbnlliuJlh dnrtieaiotBe o fnbacoeaer eFd nni

u r surricri a nalam fnied ni m aeomnrSiavnsdlmanggl lla eoteciv aeuxnrrgo csinmsSeletetmcauca oioen tutlry l cd oripsryeleecitaelcdpplfstt seea tpv ed v.o$tedleryrbnaepee Lu3ittoeaorleomee-mmp irgiodeatulnncam ai ti tn,bt rsihtlecdeifenue io aeilpeea eto e.ic,lhvtsetmr mmnblqtpdi edun, ce n i-ssindt eahmetpn trlsllo.v1 omdnpn yneevdozsolreesoinnriirelueodfvisiiei d

esa.oml ra.ae s la i myls na ns rlTtitcssicttr inaSsiuG pauo iolpeg setlc nyy LuoleonyimtlLnodbrwenmp batmnetinLtssisbeiaa allbave oLilsa edwptB teoi peaaan oaty ii necssog.oGLylisi hhii

acli4-iaitfpehrowEtw aibdo(ynoslap.inb/fInng dnvhEeP>aiewem uieroeml ttfstoP nmr iiexlds --n- iden i=.rtAmwume ee "s eeotrotoivucsca4t-ntLn lmheei .oir/ blrryc"nac/RjLoy

ntaet, eibtui ol 6.w e shtue ng rlae iy $ 2u9t,r %-9suer a6rsa nkjpd.mdmaaLrpr

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In